858 related articles for article (PubMed ID: 25936321)
1. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
[TBL] [Abstract][Full Text] [Related]
2. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
[TBL] [Abstract][Full Text] [Related]
3. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.
Safarova MS; Ezhov MV; Afanasieva OI; Matchin YG; Atanesyan RV; Adamova IY; Utkina EA; Konovalov GA; Pokrovsky SN
Atheroscler Suppl; 2013 Jan; 14(1):93-9. PubMed ID: 23357149
[TBL] [Abstract][Full Text] [Related]
4. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study).
Ikeda K; Takahashi T; Yamada H; Matsui K; Sawada T; Nakamura T; Matsubara H;
Eur J Prev Cardiol; 2013 Dec; 20(6):1069-79. PubMed ID: 22689416
[TBL] [Abstract][Full Text] [Related]
6. Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins.
Ezhov MV; Il'ina LN; Safarova MS; Afanasieva OI; Adamova IY; Atanesyan RV; Konovalov GA; Akchurin RS; Pokrovsky SN
Atheroscler Suppl; 2013 Jan; 14(1):101-5. PubMed ID: 23357150
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia.
Bos S; Duvekot MH; Touw-Blommesteijn AC; Verhoeven AJ; Mulder MT; Watts GF; Sijbrands EJ; Roeters van Lennep JE
Atherosclerosis; 2015 Sep; 242(1):226-9. PubMed ID: 26222903
[TBL] [Abstract][Full Text] [Related]
8. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
Kroon AA; van Asten WN; Stalenhoef AF
Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.
Heigl F; Hettich R; Lotz N; Reeg H; Pflederer T; Osterkorn D; Osterkorn K; Klingel R
Atheroscler Suppl; 2015 May; 18():154-62. PubMed ID: 25936320
[TBL] [Abstract][Full Text] [Related]
10. The impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a): Objectives and methods of a randomised controlled trial.
Khan TZ; Pottle A; Pennell DJ; Barbir MS
Atheroscler Suppl; 2015 May; 18():103-8. PubMed ID: 25936312
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes.
Hohenstein B; Julius U; Lansberg P; Jaeger B; Mellwig KP; Weiss N; Graehlert X; Roeder I; Ramlow W
Atheroscler Suppl; 2017 Nov; 30():180-186. PubMed ID: 29096835
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Long-Term Atorvastatin Therapy on Carotid Intima-Media Thickness of Children With Dyslipidemia.
Karapostolakis G; Vakaki M; Attilakos A; Marmarinos A; Papadaki M; Koumanidou C; Alexopoulou E; Gourgiotis D; Garoufi A
Angiology; 2021 Apr; 72(4):322-331. PubMed ID: 33242982
[TBL] [Abstract][Full Text] [Related]
13. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
14. Effects of Lipoprotein apheresis on the Lipoprotein(a) levels in the long run.
Groß E; Hohenstein B; Julius U
Atheroscler Suppl; 2015 May; 18():226-32. PubMed ID: 25936330
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (a) and coronary heart disease - is there an efficient secondary prevention?
Mellwig KP; Horstkotte D; van Buuren F
Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):18-21. PubMed ID: 28233270
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
17. The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study.
Duman D; Demirtunc R; Sahin S; Esertas K
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1007-11. PubMed ID: 18163011
[TBL] [Abstract][Full Text] [Related]
18. Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern.
von Dryander M; Fischer S; Passauer J; Müller G; Bornstein SR; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):39-44. PubMed ID: 23357139
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
Leebmann J; Roeseler E; Julius U; Heigl F; Spitthoever R; Heutling D; Breitenberger P; Maerz W; Lehmacher W; Heibges A; Klingel R;
Circulation; 2013 Dec; 128(24):2567-76. PubMed ID: 24056686
[TBL] [Abstract][Full Text] [Related]
20. LDL-apheresis in two patients with extremely elevated lipoprotein (a) levels.
Bambauer R; Schiel R; Keller HE; Latza R
Int J Artif Organs; 1995 May; 18(5):286-90. PubMed ID: 8567105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
